BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17961031)

  • 1. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery.
    Liu JK; Fleseriu M; Delashaw JB; Ciric IS; Couldwell WT
    Neurosurg Focus; 2007; 23(3):E8. PubMed ID: 17961031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of recurrent and refractory Cushing disease.
    Aghi MK
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):560-8. PubMed ID: 18711406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
    Kelly DF
    Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
    Dehdashti AR; Gentili F
    Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.
    Seltzer J; Lucas J; Commins D; Lerner O; Lerner A; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E10. PubMed ID: 25639312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of recurrent Cushing's disease.
    Liubinas SV; Porto LD; Kaye AH
    J Clin Neurosci; 2011 Jan; 18(1):7-12. PubMed ID: 20851608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
    Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
    Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Cushing's disease after failed surgery--a review.
    McLaughlin N; Kassam AB; Prevedello DM; Kelly DF
    Can J Neurol Sci; 2011 Jan; 38(1):12-21. PubMed ID: 21156424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosurgical Management of Patients With Persistent or Recurrent Cushing Disease After Prior Transsphenoidal Surgery: A Management Algorithm Based on a 25-Year Experience.
    Hughes JD; Young WF; Chang AY; Link MJ; Garces YI; Laack NN; Thompson GB; Pollock BE
    Neurosurgery; 2020 Apr; 86(4):557-564. PubMed ID: 31140563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease.
    Wong A; Eloy JA; Liu JK
    Neurosurg Focus; 2015 Feb; 38(2):E9. PubMed ID: 25639327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing disease: use of perioperative serum cortisol measurements in early determination of success following pituitary surgery.
    Krikorian A; Abdelmannan D; Selman WR; Arafah BM
    Neurosurg Focus; 2007; 23(3):E6. PubMed ID: 17961022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy.
    Smith PW; Turza KC; Carter CO; Vance ML; Laws ER; Hanks JB
    J Am Coll Surg; 2009 Jun; 208(6):1059-64. PubMed ID: 19476892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
    Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
    Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.
    Espinosa-de-Los-Monteros AL; Sosa-Eroza E; Espinosa E; Mendoza V; Arreola R; Mercado M
    Endocr Pract; 2017 Jul; 23(7):759-767. PubMed ID: 28332874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging.
    Jagannathan J; Sheehan JP; Jane JA
    Neurosurg Focus; 2007; 23(3):E3. PubMed ID: 17961018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapy of Cushing's disease in adults and children: an update.
    Juszczak A; Ertorer ME; Grossman A
    Horm Metab Res; 2013 Feb; 45(2):109-17. PubMed ID: 23225246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options after surgical failure in Cushing's disease: A critical review.
    Rubinstein G; Osswald A; Zopp S; Ritzel K; Theodoropoulou M; Beuschlein F; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101270. PubMed ID: 31036383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.